These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35813681)

  • 1. Prevalence of COVID-19 Vaccine Side Effects among Early-Vaccinated Healthcare Workers in Eastern Ethiopia.
    Jarso G; Gebi W; Abdo M; Lemma M; Abebe E; Lemessa B; Deressa BT
    Ethiop J Health Sci; 2022 May; 32(3):473-484. PubMed ID: 35813681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-reported side effects of the Oxford AstraZeneca COVID-19 vaccine among healthcare workers in Ethiopia, Africa: A cross-sectional study.
    Yesuf EA; Riad A; Sofi-Mahmudi A; Sudhakar M; Mekonnen A; Endalkachew S; Mama F; Muhidin S; Ayele B; Yahya M; Usman A; Abafita J; Klugar M
    Front Public Health; 2022; 10():937794. PubMed ID: 35928493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse events following immunization with ChAdOx1 nCoV-19 and BBIBP-CorV vaccine: A comparative study among healthcare professionals of Nepal.
    Rayamajhi S; Rafi MA; Tripathi N; Dongol AS; Pandey M; Rayamajhi S; Bhandari S; Shrestha P; Hasan MT; Hossain MG
    PLoS One; 2022; 17(8):e0272729. PubMed ID: 35947626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of adverse events among healthcare workers following the Janssen COVID-19 vaccine in Tigray, Ethiopia.
    Abera BT; Teka H; Berhe E; Gebru MA; Zenebe D; Abraha HE; Hailu A
    Sci Rep; 2024 Feb; 14(1):3255. PubMed ID: 38332047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reporting adverse events of ChAdOx1 nCoV-19 coronavirus vaccine (Recombinant) among the vaccinated healthcare professionals: A cross-sectional survey.
    Kaur S; Singh A; Saini S; Rohilla L; Kaur J; Chandi A; Kaur G; Singh M; Kumar P; Soni SL; Kajal K; Naik NB; Malhotra P; Verma S; Gupta M; Devnani M; Das K; Pandav SS; Puri GD
    Indian J Med Res; 2022 Jan; 155(1):123-128. PubMed ID: 35859438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active Symptom-Based Surveillance of Adverse Events Following Immunization Among Individuals Vaccinated with ChAdOx1 nCoV-19 Coronavirus Vaccine in a Tertiary Hospital of Kerala.
    Jose M; Rajmohan P; Thomas J; Krishna S; Antony B; Gopinathan UU; Iyyapan EM; Porinchu RM; Jose P; Raphael L; Kuttichira P
    Curr Drug Saf; 2022; 17(4):327-334. PubMed ID: 35135453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ChAdOx1 nCoV-19 Vaccine Side Effects among Healthcare Workers in Trinidad and Tobago.
    Gopaul CD; Ventour D; Thomas D
    Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety, immunogenecity and effectiveness of ChAdOx1 nCoV-19 vaccine during the second wave of pandemic in India: a real-world study.
    Chavan P; Dey R; Castelino R; Kamble A; Poladia P; Bagal R; Jadhav M; Shirsat A; Chavan A; Dhumal S; Kumar S; Krishnamurty MN; Bhat V; Bhattacharjee A; Gota V
    Drug Metab Pers Ther; 2023 Sep; 38(3):227-236. PubMed ID: 37098129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance on Adverse Events Following COVISHIELD (ChAdOx1 nCoV-19) vaccination in Goa, India: An Observational Study.
    Jose D; Dhupdale N; Cacodcar JA; Kamat U
    Curr Drug Saf; 2023; 18(4):516-527. PubMed ID: 35927820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactogenicity to ChAdOx1 nCoV-19 vaccine in health care workers: A multicenter observational study in Sri Lanka.
    Undugodage C; Dissanayake U; Kumara H; Samarasekera B; Yapa L; Ganegma R; Wickramasinghe WK; Samarakoon S; Wijesinghe P; Wijemanne U; Sandaruwan HC; Neranjan R; Illeperuma Pk PK; Thenuwara HM; Amashakya GA; Dasanayake HD; Jayasooriya SC; Kalubandara BS; Madurawala NC; Prasath T; Perera N
    Ceylon Med J; 2021 Dec; 66(4):177-184. PubMed ID: 35570336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse reactions following COVID-19 vaccine among healthcare professionals working in Ethiopia: a facility-based cross-sectional study.
    Asefa A; Derjachew N; Belete AM; Talargia F; Melese DM; Getachew B
    Front Public Health; 2023; 11():1187948. PubMed ID: 38026432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Side Effects of COVID-19 Inactivated Virus vs. Adenoviral Vector Vaccines: Experience of Algerian Healthcare Workers.
    Lounis M; Rais MA; Bencherit D; Aouissi HA; Oudjedi A; Klugarová J; Pokorná A; Klugar M; Riad A
    Front Public Health; 2022; 10():896343. PubMed ID: 35651866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADR Profile of the Covishield Vaccine Among Healthcare Workers in a Tertiary Care Teaching Hospital in India.
    Deb T; Garg R; Kaur M; Beniwal A; Gupta V
    Curr Drug Saf; 2022; 17(4):344-349. PubMed ID: 35049437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of AstraZeneca COVID-19 vaccine side effects among Nigist Eleni Mohammed memorial comprehensive specialized hospital health workers. Cross sectional survey.
    Desalegn M; Garoma G; Tamrat H; Desta A; Prakash A
    PLoS One; 2022; 17(6):e0265140. PubMed ID: 35749520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, immunogenicity & effectiveness of the COVID-19 vaccine among healthcare workers in a tertiary care hospital.
    Kataria S; Sharma P; Singh MK; Deswal V; Kumar K; Alam S; Gupta V; Phogat R; Sarma S; Patil N; Dutt R; Singh P; Saxena R; Trehan N
    Indian J Med Res; 2022; 155(5&6):518-525. PubMed ID: 36348600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactogenicity among health care workers following a BNT162b2 or mRNA-1273 second dose after priming with a ChAdOx1 nCOV-19 vaccine.
    Baldolli A; Fournier A; Verdon R; Michon J
    Clin Microbiol Infect; 2022 Jun; 28(6):885.e1-885.e5. PubMed ID: 35182759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse Events in Healthcare Workers after the First Dose of ChAdOx1 nCoV-19 or BNT162b2 mRNA COVID-19 Vaccination: a Single Center Experience.
    Kim SH; Wi YM; Yun SY; Ryu JS; Shin JM; Lee EH; Seo KH; Lee SH; Peck KR
    J Korean Med Sci; 2021 Apr; 36(14):e107. PubMed ID: 33847085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse Reactions Following the First Dose of ChAdOx1 nCoV-19 Vaccine and BNT162b2 Vaccine for Healthcare Workers in South Korea.
    Bae S; Lee YW; Lim SY; Lee JH; Lim JS; Lee S; Park S; Kim SK; Lim YJ; Kim EO; Jung J; Kwon HS; Kim TB; Kim SH
    J Korean Med Sci; 2021 May; 36(17):e115. PubMed ID: 33942579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study.
    Menni C; May A; Polidori L; Louca P; Wolf J; Capdevila J; Hu C; Ourselin S; Steves CJ; Valdes AM; Spector TD
    Lancet Infect Dis; 2022 Jul; 22(7):1002-1010. PubMed ID: 35405090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superficial venous thrombosisas a possible consequence of ChAdOx1 nCoV-19 vaccine: two case reports.
    Sah MK; Singh BM; Sinha P; Devkota P; Yadav SK; Shrestha J; Shrestha A
    J Med Case Rep; 2022 May; 16(1):182. PubMed ID: 35524323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.